Are outpatient anticoagulation management services the wave of the future (again)?
作者信息
Samuelson Bannow Bethany
机构信息
The Hemophilia Center at Oregon Health and Science University Portland Oregon USA.
出版信息
Res Pract Thromb Haemost. 2022 May 30;6(4):e12735. doi: 10.1002/rth2.12735. eCollection 2022 May.
Abstract
摘要
相似文献
1
Are outpatient anticoagulation management services the wave of the future (again)?
Res Pract Thromb Haemost. 2022 May 30;6(4):e12735. doi: 10.1002/rth2.12735. eCollection 2022 May.
2
Comparison of clinical outcomes of edoxaban versus apixaban, dabigatran, rivaroxaban, and vitamin K antagonists in patients with atrial fibrillation in Germany: A real-world cohort study.
Int J Cardiol. 2022 Jan 1;346:93-99. doi: 10.1016/j.ijcard.2021.11.008. Epub 2021 Nov 12.
3
Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.
PLoS One. 2015 Dec 30;10(12):e0144856. doi: 10.1371/journal.pone.0144856. eCollection 2015.
4
Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation. An indirect comparison analysis.
Thromb Haemost. 2014 May 5;111(5):981-8. doi: 10.1160/TH14-02-0118. Epub 2014 Feb 28.
5
Anticoagulant therapy with the oral direct factor Xa inhibitors rivaroxaban, apixaban and edoxaban and the thrombin inhibitor dabigatran etexilate in patients with hepatic impairment.
Clin Pharmacokinet. 2013 Apr;52(4):243-54. doi: 10.1007/s40262-013-0034-0.
6
Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran, rivaroxaban and edoxaban in three patient subgroups.
Int J Cardiol. 2016 Feb 1;204:88-94. doi: 10.1016/j.ijcard.2015.11.084. Epub 2015 Nov 17.
7
Comparative study of hemorrhagic and ischemic complications among anticoagulants in patients undergoing cryoballoon ablation for atrial fibrillation.
J Cardiol. 2017 Jan;69(1):11-15. doi: 10.1016/j.jjcc.2016.04.009. Epub 2016 May 7.
8
Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013.
Europace. 2015 Feb;17(2):187-93. doi: 10.1093/europace/euu225. Epub 2014 Sep 18.
9
Management of Oral Anticoagulation Therapy After Gastrointestinal Bleeding: Whether to, When to, and How to Restart an Anticoagulation Therapy.
Ann Pharmacother. 2017 Nov;51(11):1000-1007. doi: 10.1177/1060028017717019. Epub 2017 Jun 22.
10
Measurement of the direct oral anticoagulants apixaban, dabigatran, edoxaban, and rivaroxaban in human plasma using turbulent flow liquid chromatography with high-resolution mass spectrometry.
Ther Drug Monit. 2014 Oct;36(5):597-605. doi: 10.1097/FTD.0000000000000059.
引用本文的文献
1
Safe and effective anticoagulation use: case studies in anticoagulation stewardship.
J Thromb Haemost. 2025 Mar;23(3):779-789. doi: 10.1016/j.jtha.2024.11.024. Epub 2024 Dec 10.
本文引用的文献
1
Optimization of DOAC management services in a centralized anticoagulation clinic.
Res Pract Thromb Haemost. 2022 May 5;6(3):e12696. doi: 10.1002/rth2.12696. eCollection 2022 Mar.
2
Assessment of a Pharmacist-Led Direct Oral Anticoagulant Monitoring Clinic.
Can J Hosp Pharm. 2021 Winter;74(1):7-14. Epub 2021 Jan 1.
3
Drug-drug interaction (DDI) with direct oral anticoagulant (DOAC) in patients with cancer.
J Med Vasc. 2020 Nov;45(6S):6S31-6S38. doi: 10.1016/S2542-4513(20)30517-4.
4
2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Solution Set Oversight Committee.
J Am Coll Cardiol. 2021 Feb 9;77(5):629-658. doi: 10.1016/j.jacc.2020.09.011. Epub 2020 Nov 26.
5
Identifying Adherence Patterns Across Multiple Medications and Their Association With Health Outcomes in Older Community-Dwelling Adults With Multimorbidity.
Value Health. 2020 Aug;23(8):1063-1071. doi: 10.1016/j.jval.2020.03.016. Epub 2020 Jul 22.
6
Rivaroxaban or Enoxaparin in Nonmajor Orthopedic Surgery.
N Engl J Med. 2020 May 14;382(20):1916-1925. doi: 10.1056/NEJMoa1913808. Epub 2020 Mar 29.
7
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer.
N Engl J Med. 2020 Apr 23;382(17):1599-1607. doi: 10.1056/NEJMoa1915103. Epub 2020 Mar 29.
8
Select Drug-Drug Interactions With Direct Oral Anticoagulants: JACC Review Topic of the Week.
J Am Coll Cardiol. 2020 Mar 24;75(11):1341-1350. doi: 10.1016/j.jacc.2019.12.068.
9
Real-World Adherence and Persistence to Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis.
Circ Cardiovasc Qual Outcomes. 2020 Mar;13(3):e005969. doi: 10.1161/CIRCOUTCOMES.119.005969. Epub 2020 Mar 9.
10
Patient-level adherence and interventions in an interdisciplinary DOAC clinic.
Thromb Res. 2019 Jul;179:34-36. doi: 10.1016/j.thromres.2019.04.021. Epub 2019 Apr 22.
Zotero 插件